Avoro Capital Advisors LLC Madrigal Pharmaceuticals, Inc. Transaction History

Avoro Capital Advisors LLC

$6.65 Billion
Q3 2024

A detailed history of Avoro Capital Advisors LLC transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Avoro Capital Advisors LLC holds 2,029,000 shares of MDGL stock, worth $626 Million. This represents 6.48% of its overall portfolio holdings.

Number of Shares

2,029,000

Previous 2,055,555 1.29%

Holding current value

$626 Million

Previous $576 Million 25.23%

% of portfolio

6.48%

Previous 7.86%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$212.22 - $292.96 $5.64 Million - $7.78 Million	-26,555 Reduced 1.29%	2,029,000 $431 Million
Q2 2024 Aug 14, 2024	BUY	$193.33 - $291.99 $21.5 Million - $32.4 Million	111,111 Added 5.71%	2,055,555 $576 Million
Q1 2024 May 15, 2024	BUY	$171.37 - $283.23 $9.52 Million - $15.7 Million	55,556 Added 2.94%	1,944,444 $519 Million
Q4 2023 Feb 14, 2024	BUY	$120.4 - $237.13 $40.2 Million - $79.2 Million	333,888 Added 21.47%	1,888,888 $437 Million
Q3 2023 Nov 14, 2023	BUY	$146.04 - $225.78 $5.82 Million - $9 Million	39,849 Added 2.63%	1,555,000 $227 Million
Q2 2023 Aug 14, 2023	SELL	$203.88 - $312.0 $30.9 Million - $47.3 Million	-151,515 Reduced 9.09%	1,515,151 $350 Million
Q1 2023 May 15, 2023	BUY	$231.06 - $307.08 $1.54 Million - $2.05 Million	6,666 Added 0.4%	1,666,666 $404 Million
Q4 2022 Feb 14, 2023	BUY	$58.39 - $296.54 $7.3 Million - $37.1 Million	125,000 Added 8.14%	1,660,000 $482 Million
Q2 2022 Aug 15, 2022	BUY	$58.04 - $100.2 $6.38 Million - $11 Million	110,000 Added 7.72%	1,535,000 $110 Million
Q1 2021 May 17, 2021	BUY	$108.54 - $125.2 $21.7 Million - $25 Million	200,000 Added 16.33%	1,425,000 $167 Million
Q4 2020 Feb 16, 2021	BUY	$110.06 - $133.7 $36.9 Million - $44.8 Million	335,000 Added 37.64%	1,225,000 $136 Million
Q3 2020 Nov 16, 2020	BUY	$99.78 - $124.21 $53.9 Million - $67.1 Million	540,000 Added 154.29%	890,000 $106 Million
Q2 2020 Aug 14, 2020	BUY	$60.13 - $125.71 $60,130 - $125,710	1,000 Added 0.29%	350,000 $39.6 Million
Q4 2019 Feb 14, 2020	SELL	$84.28 - $118.5 $927,080 - $1.3 Million	-11,000 Reduced 3.06%	349,000 $31.8 Million
Q2 2019 Aug 14, 2019	BUY	$91.13 - $142.5 $4.56 Million - $7.13 Million	50,000 Added 16.13%	360,000 $37.7 Million
Q1 2019 May 15, 2019	BUY	$103.48 - $143.84 $8.8 Million - $12.2 Million	85,000 Added 37.78%	310,000 $38.8 Million
Q4 2018 Feb 14, 2019	SELL	$94.77 - $215.54 $22.6 Million - $51.3 Million	-238,000 Reduced 51.4%	225,000 $25.4 Million
Q3 2018 Nov 14, 2018	SELL	$207.3 - $300.31 $5.5 Million - $7.97 Million	-26,536 Reduced 5.42%	463,000 $99.1 Million
Q2 2018 Aug 14, 2018	BUY	$101.55 - $313.9 $49.7 Million - $154 Million	489,536 New	489,536 $137 Million

Others Institutions Holding MDGL

# of Institutions

297

Shares Held

22M

Call Options Held

819K

Put Options Held

640K

View Full List

About MADRIGAL PHARMACEUTICALS, INC.

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.28B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

More about MDGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avoro Capital Advisors LLC with notifications on news.

Account

Avoro Capital Advisors LLC Madrigal Pharmaceuticals, Inc. Transaction History